首页> 新闻动态> 清华-伯克利学院考察易特科(前海安测)“AI-TCM”

清华-伯克利学院考察易特科(前海安测)“AI-TCM”

2019-11-01 18:32

2019年10月31日,清华-伯克利深圳学院副院长陈伟坚教授、生物医药与健康专家秦培武教授、创新教育中心车滨杰主任率团队一行10余人莅临易特科集团(前海安测)深圳总部考察“AI+中医”创新及产业化,洽谈科研及联合培养人才等战略合作。易特科集团董事长兼CEO张贯京先生率联合创始人兼CTO葛新科博士,执行总裁兼COO罗文高先生,联席总裁宋云明博士,总工程师兼投资部总经理高伟明博士,副总工程师张红治博士和周亮博士,研究员陈琦博士、唐苏明博士、梁昊原博士、邢烁女士等团队热情接待。

访问期间,专家教授团首先参观了易特科集团(前海安测)智慧医疗实验室和研发中心,观看了安测中医四诊仪、中医体质辨识仪等产品演示,详细了解了易特科集团在中医现代化领域的研发方向及创新成果。经过实地考察,专家团非常看好易特科集团智慧中医辅助辨识平台的应用前景,并对易特科集团在“AI+中医”领域的研发创新给予了指导意见。




座谈会上,双方就“AI+中医”科研合作和联合人才培养计划等事项进行了深入交流。张贯京董事长和罗文高总裁先后向各位专家教授介绍了易特科集团科研团队将中医辨证论治理论与互联网、人工智能等技术相结合,建立中医AI辅助诊断大数据平台,辅助各级医疗卫生机构对亚健康群体和中老年群体提供常见重大疾病筛查、中医治未病等服务的经验。张总和罗总均表示,作为中医领域的行业资深专家,各位专家的莅临指导和合作支持给易特科集团核心技术团队提供了一次难得的交流学习机会,希望双方今后在“AI+中医”领域加强交流与合作,进一步推动现代科学技术在中医基础研究中的应用。


随后,专家团也就中医技术应用、人才交流、科研项目等方面交换了意见,并达成了一致战略合作共识,双方均表示今后将在“AI+中医”领域开展深度交流与合作,做好中医传承与创新,推动现代化中医诊疗技术走向世界!


Tsinghua-Berkeley Shenzhen Institute visited E-Techco (Qianhai AnyCheck) "AI-TCM"

On October 31th, 2019, Professor Chen Weijian, Vice President of Tsinghua-Berkeley Shenzhen Institute, Professor Qin Peiwu, a biomedical and health expert, Director of the Innovation Education Center, Che Binjie and other 10 researchers visited E-Techco (Qianhai AnyCheck) to inspect the innovation and industry of “AI+ TCM” and discuss strategic cooperation. Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, led the co-founder and CTO Dr. Ge Xinke, executive President and COO Luo Wengao , co-president Dr. Song Yunming, Chief Engineer and General Manager of Investment Department Dr. Gao Weiming, Deputy Chief Engineer Dr. Zhang Hongzhi and Dr. Zhou Liang, Researcher Dr. Chen Qi, Dr. Tang Suming, Dr. Liang Haoyuan, Ms. Xing Shuo and other teams warmly received.

During the visit, the expert and professor group first visited E-Techco Group (Qianhai AnyCheck) Smart Medical Laboratory and R&D Center, and watched the product demonstrations of AnyCheck Chinese Medicine Four Diagnostic Instrument and the TCM Physical Fitness Appraisal, and learned more about E-Techco Group. R&D direction and innovation achievements in the field of modernization of Chinese medicine. After field visits, the expert group is very optimistic about the application prospects of E-Techco Group's intelligent Chinese medicine auxiliary identification platform, and gives guidance to E-Techco Group in the research and development of "AI+ TCM".

At the symposium, the two sides conducted in-depth exchanges on matters such as "AI+ TCM" scientific research cooperation. Chairman Zhang Guanjing and Mr. Luo Wengao introduced to the experts and professors that E-Techco Group's scientific research team combined the theory of TCM syndrome differentiation with the Internet and artificial intelligence to establish a Chinese medicine AI-aided diagnosis big data platform to assist medical and health institutions at all levels in sub-health groups. The elderly population provides experience in screening for common major diseases and services such as Chinese medicine treatment. Mr. Zhang and Mr. Luo said that as a senior expert in the field of Chinese medicine, the guidance and cooperation support of the experts provided a rare exchange and learning opportunity for E-Techco Group core technical team. I hope that the two sides will strengthen exchanges and cooperation in the field of “AI+ TCM” in the future. Further promote the application of modern science and technology in basic research of Chinese medicine.

Subsequently, the expert group exchanged opinions on TCM technology application, talent exchange, scientific research projects, etc., and reached a consensus on strategic cooperation. Both parties indicated that they will carry out in-depth exchanges and cooperation in the field of “AI+ TCM” in the future and do a good job in TCM inheritance, promote modern Chinese medicine diagnosis and treatment technology to the world!


按年份查询

全部

2019

2018

2017

2016

2015

2014

2013

搜索